Literature DB >> 17351031

Integrating Chinese and conventional medicine in colorectal cancer treatment.

Tai Lahans1.   

Abstract

The Chinese have been integrating cancer treatment for the past 60 years. Using conventional and Chinese traditional medicine, this integration has evolved into a sophisticated hybrid of medicine that has generated a great deal of well-designed research demonstrating that the use of combined care can improve outcomes for patients with cancer. This article seeks to explain the integration in terms of treatment of colorectal cancer and a colorectal cancer case with Duke's stage C adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351031     DOI: 10.1177/1534735406298991

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  2 in total

1.  Feature representation in the biclustering of symptom-herb relationship in Chinese medicine.

Authors:  Josiah Poon; Zhe Luo; Run-shun Zhang
Journal:  Chin J Integr Med       Date:  2011-09-11       Impact factor: 1.978

2.  Traditional Chinese medicine formula T33 inhibits the proliferation of human colorectal cancer cells by inducing autophagy.

Authors:  Yu-Te Liu; Bor-Show Tzang; JiaLe Yow; Yi-Hsuan Chiang; Chih-Yang Huang; Tsai-Ching Hsu
Journal:  Environ Toxicol       Date:  2022-01-07       Impact factor: 4.109

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.